Clinical trial
Assessment of Association Between 3rd Dose of mRNA Vaccine and Risk of SARS-CoV-2 Infection in Kidney Transplant Recipients, Safety and Immunogenicity Assessment.
NCT05483725 is registered in ClinicalTrials.gov with Institute for Clinical and Experimental Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessment of Association Between 3rd Dose of mRNA Vaccine and Risk of SARS-CoV-2 Infection in Kidney Transplant Recipients, Safety and Immunogenicity Assessment.
- Lead sponsor
- Institute for Clinical and Experimental Medicine
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 4, 2021
- Completion date
- December 31, 2024
- Enrollment
- 108 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
covid-19, kidney diseases, kidney transplant; complications, rejection acute renal, rejection chronic renal, vaccine adverse reaction